Skip to content
Screener

Enanta Pharmaceuticals ENTA Q1 2025 earnings

Reported May 12, 2025 · Before market open

Revenue$14.9MMiss by $1.0M
EPS-$1.06Miss by $0.02
Revenue estimate$16.0M
EPS estimate-$1.04

Next report

Nov 16, 2026 (in 2 months)
Revenue estimate$15.7M
EPS estimate-$0.77

FAQ

When did Enanta Pharmaceuticals report Q1 2025 earnings?
Enanta Pharmaceuticals (ENTA) reported Q1 2025 earnings on May 12, 2025 before market open.
What were Enanta Pharmaceuticals's Q1 2025 revenue and EPS?
Enanta Pharmaceuticals reported revenue of $14.9M and eps of $-1.06 for Q1 2025.
Did Enanta Pharmaceuticals beat estimates in Q1 2025?
Revenue missed the consensus estimate of $16.0M by $1.0M. EPS missed the consensus estimate of $-1.04 by $0.02.
How did Enanta Pharmaceuticals's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 12.5% from $17.1M a year earlier and eps grew 27.9% from $-1.47.
Where can I find Enanta Pharmaceuticals's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-069155) and the 10-Q periodic report (0000950170-25-071340) directly on SEC EDGAR. The filing index links above go to sec.gov.